🧔♂️ A friendly human may check it before it goes live. More news here
New Zealand medtech startup Wellumio nets $7.3m pre-series A
Wellumio, a New Zealand-based medical technology firm developing portable stroke diagnostic devices, has raised US$7.3 million in its first close of a pre-series A funding round.
The funding was led by Nuance Connected Capital and supported by several investors, including Icehouse Ventures, NZ Growth Capital Partners, and international programs.
The funding will support further clinical development, team expansion, and manufacturing refinement.
Wellumio’s Axana device is designed to provide MRI-based stroke assessments at the point of care, aiming to deliver rapid diagnosis without the need for contrast agents or specialized infrastructure.
The company explains the device uses proprietary Pulsed Gradient Free Mapping technology, which has shown promising results in preclinical and early human trials.
Wellumio’s technology targets a global stroke diagnostics market estimated at over US$8.9 billion, with the goal of enabling faster treatment and improved outcomes for stroke patients.
🔗 Source: Wellumio
🧠 Food for thought
Implications, context, and why it matters.
Wellumio’s funding backs an early-stage idea in a crowded field
- The funding is new. The core concept reuses portable magnetic resonance (MR) systems first built for industrial field work such as analyzing rock samples 1.
- Wellumio has enrolled its first patient in Australia for a feasibility, safety, and usability assessment study 2.
- Rivals already sell similar gear. Hyperfine is commercializing its Swoop portable MRI system, and it published results from a 95-patient prospective multi-center observational study that compared original and next-generation Swoop scanners plus diffusion-weighted imaging (DWI) sequences for ischemic lesion detection 3.
The disruption comes from bringing the scanner to the patient
- Wellumio’s Axana device fits a move toward bedside diagnostics rather than sending patients to large scanners 1.
- Smaller hospitals without full-scale MRI often transfer stroke patients for imaging. That trip can slow care and strain staffing 1.
- Competition also includes software. Several groups are building AI tools that speed up interpretation of computed tomography (CT) and CT angiography (CTA) scans used in many acute stroke workflows 4.
- Wellumio will need strong clinical performance and a clear edge over CT/CTA software upgrades already used by many stroke-care teams 4.
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.